F

Fresenius Medical Care AG & Co KGaA
NYSE:FMS

Watchlist Manager
Fresenius Medical Care AG & Co KGaA
NYSE:FMS
Watchlist
Price: 22.66 USD 0.85% Market Closed
Market Cap: $13.3B

Wall St Price Targets

FMS Price Targets Summary
Fresenius Medical Care AG & Co KGaA

Wall Street analysts forecast FMS stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for FMS is 24.22 USD with a low forecast of 12.74 USD and a high forecast of 35.98 USD.

Lowest Forecast
Price Target
12.74 USD
44% Downside
Average Forecast
Price Target
24.22 USD
7% Upside
Highest Forecast
Price Target
35.98 USD
59% Upside
Fresenius Medical Care AG & Co KGaA Competitors:
Price Targets
CNC
Concurrent Technologies PLC
6% Upside
TRI
Thomson Reuters Corp
-14% Downside
ALG
Alamo Group Inc
20% Upside

Revenue
Forecast

5% / Year
Past Growth
4% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
5% / Year
Past Growth
4% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Over the last 13 years, the compound annual growth rate for Revenue has been 5%. The projected CAGR for the next 8 years is 4%.

Gross Profit
Forecast

2% / Year
Past Growth
5% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss
2% / Year
Past Growth
5% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Over the last 13 years, the compound annual growth rate for Gross Profit has been 2%. The projected CAGR for the next 8 years is 5%.

Operating Income
Forecast

0% / Year
Past Growth
8% / Year
Estimated Growth
Estimates Accuracy
-9%
Average Miss
0% / Year
Past Growth
8% / Year
Estimated Growth
Estimates Accuracy
-9%
Average Miss

Over the last 13 years, the compound annual growth rate for Operating Income has been 0%. The projected CAGR for the next 8 years is 8%.

Pre-Tax Income
Forecast

0% / Year
Past Growth
9% / Year
Estimated Growth
Estimates Accuracy
-6%
Average Miss
0% / Year
Past Growth
9% / Year
Estimated Growth
Estimates Accuracy
-6%
Average Miss

Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 0%. The projected CAGR for the next 3 years is 9%.

Net Income
Forecast

0% / Year
Past Growth
8% / Year
Estimated Growth
Estimates Accuracy
-7%
Average Miss
0% / Year
Past Growth
8% / Year
Estimated Growth
Estimates Accuracy
-7%
Average Miss

Over the last 13 years, the compound annual growth rate for Net Income has been 0%. The projected CAGR for the next 8 years is 8%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is FMS's stock price target?
Price Target
24.22 USD

According to Wall Street analysts, the average 1-year price target for FMS is 24.22 USD with a low forecast of 12.74 USD and a high forecast of 35.98 USD.

What is the Revenue forecast for Fresenius Medical Care AG & Co KGaA?
Projected CAGR
4%

Over the last 13 years, the compound annual growth rate for Revenue has been 5%. The projected CAGR for the next 8 years is 4%.

What is the Gross Profit forecast for Fresenius Medical Care AG & Co KGaA?
Projected CAGR
5%

Over the last 13 years, the compound annual growth rate for Gross Profit has been 2%. The projected CAGR for the next 8 years is 5%.

What is the Operating Income forecast for Fresenius Medical Care AG & Co KGaA?
Projected CAGR
8%

Over the last 13 years, the compound annual growth rate for Operating Income has been 0%. The projected CAGR for the next 8 years is 8%.

What is the Pre-Tax Income forecast for Fresenius Medical Care AG & Co KGaA?
Projected CAGR
9%

Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 0%. The projected CAGR for the next 3 years is 9%.

What is the Net Income forecast for Fresenius Medical Care AG & Co KGaA?
Projected CAGR
8%

Over the last 13 years, the compound annual growth rate for Net Income has been 0%. The projected CAGR for the next 8 years is 8%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett